SurgePays, Inc. (NASDAQ:SURG - Get Free Report) was the target of a large decrease in short interest during the month of May. As of May 15th, there was short interest totalling 451,500 shares, a decrease of 13.5% from the April 30th total of 521,700 shares. Based on an average daily trading volume, of 1,620,000 shares, the days-to-cover ratio is currently 0.3 days. Approximately 3.2% of the shares of the stock are short sold.
Analyst Ratings Changes
SURG has been the topic of several recent research reports. Wall Street Zen upgraded SurgePays from a "sell" rating to a "hold" rating in a report on Thursday, May 22nd. Ascendiant Capital Markets upped their price objective on SurgePays from $8.50 to $8.75 and gave the stock a "buy" rating in a report on Tuesday, April 22nd.
Check Out Our Latest Stock Report on SurgePays
SurgePays Stock Performance
SurgePays stock traded down $0.14 during trading on Thursday, reaching $2.81. The company had a trading volume of 106,372 shares, compared to its average volume of 638,288. SurgePays has a 52 week low of $1.05 and a 52 week high of $4.38. The firm's 50-day simple moving average is $2.72 and its 200 day simple moving average is $1.98. The firm has a market capitalization of $57.36 million, a price-to-earnings ratio of -2.49 and a beta of 0.51. The company has a current ratio of 6.24, a quick ratio of 4.70 and a debt-to-equity ratio of 0.08.
SurgePays (NASDAQ:SURG - Get Free Report) last posted its quarterly earnings results on Tuesday, May 13th. The medical equipment provider reported ($0.38) EPS for the quarter, beating analysts' consensus estimates of ($0.40) by $0.02. The business had revenue of $10.58 million for the quarter, compared to analysts' expectations of $9.80 million. SurgePays had a negative return on equity of 55.63% and a negative net margin of 27.39%. During the same period last year, the firm earned $0.07 earnings per share. Sell-side analysts forecast that SurgePays will post -1.66 earnings per share for the current fiscal year.
Institutional Investors Weigh In On SurgePays
A number of institutional investors and hedge funds have recently bought and sold shares of the business. Goldman Sachs Group Inc. bought a new stake in SurgePays during the first quarter valued at about $28,000. Jones Financial Companies Lllp raised its holdings in SurgePays by 34,091.3% during the first quarter. Jones Financial Companies Lllp now owns 51,287 shares of the medical equipment provider's stock valued at $106,000 after acquiring an additional 51,137 shares during the period. Ethos Financial Group LLC bought a new stake in shares of SurgePays in the first quarter worth about $57,000. Baader Bank Aktiengesellschaft bought a new stake in shares of SurgePays in the first quarter worth about $35,000. Finally, D.A. Davidson & CO. bought a new stake in shares of SurgePays in the first quarter worth about $25,000. 6.94% of the stock is owned by institutional investors.
SurgePays Company Profile
(
Get Free Report)
SurgePays, Inc, together with its subsidiaries, operates as a financial technology and telecom company in the United States. It operates through three segments: Mobile Virtual Network Operators, Comprehensive Platform Services, and Lead Generation. The company offers subsidized and non-subsidized mobile virtual network operators for internet connectivity through mobile broadband services to consumers; ACH banking relationships and fintech transactions platform to convenience stores; wireless top-up transactions and wireless product aggregation; and lead generation and case management solutions primarily to law firms in the mass tort industry, as well as call center activities.
Recommended Stories
Before you consider SurgePays, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SurgePays wasn't on the list.
While SurgePays currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.